Thanks for showing us that T7. A couple of comments Agree on the "Path to Profitability" political bias but I guess they had to call it something. "The Way Ahead" or "Onward" wouldn't hack it either.
Somewhere along the line I got the impression that Fukangren had a couple of months delay in activating the contract. Although the deal was signed in May, as you say, perhaps it wasn't effective until the actual process ( lodgement of application ) started in China. Taking that into account and a starting point in July or August it would explain why the deal was not included in the list of forthcoming events, IN EXPECTED ORDER as a separate entry but could easily be included in the last item on the list as a Distribution Partnership. Taking that list at face value there is a lot to happen in the next few months.
Looking to the future and a possible profit based split off I would assume that CDY would retain the MK side of things and the Advangen/Evolis side would have its own designation. Raises the possibility of further splits later with Kinera and Lyramid if each becomes profitable in their own right.
CDY Price at posting:
27.0¢ Sentiment: Buy Disclosure: Held
